Lettmann Jason bought ALXO
January 26, 2026 · Form 4 insider transaction
Lettmann Jason bought 912,000 shares of ALX Oncology Holdings Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
912,000
Price
$0.00
Total value
N/A
InsiderLettmann Jason
RoleOfficer, Director
SecurityStock option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 26, 2026
Filing dateJanuary 28, 2026
Shares owned after912,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares subject to the option vest in 48 equal monthly installments beginning on February 26, 2026.